- Home
- CUE vs GMM Comparison
CUE vs GMM Comparison
Compare CUE & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CUE | GMM |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 39.6M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CUE | GMM |
|---|---|---|
| Price | $0.42 | $1.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 249.2K | 16.3K |
| Earning Date | 11-12-2025 | 08-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.79 |
| Revenue | $7,100,000.00 | ★ $48,171,048.00 |
| Revenue This Year | $36.58 | N/A |
| Revenue Next Year | $32.10 | N/A |
| P/E Ratio | ★ N/A | $0.72 |
| Revenue Growth | N/A | ★ 41.74 |
| 52 Week Low | $0.47 | $1.23 |
| 52 Week High | $1.75 | $4.97 |
Technical Indicators
Market Signals| Indicator | CUE | GMM |
|---|---|---|
| Relative Strength Index (RSI) | 22.60 | 31.74 |
| Support Level | $0.47 | $1.28 |
| Resistance Level | $0.51 | $1.41 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 0.00 | 28.25 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.